Navigation Links
Need for considering cardiovascular risks before giving HAART for HIV/aids patients

Physicians treating HIV/AIDS patients with highly active antiretroviral treatment (HAART) needs to be careful// of the cardiac risks involved, says researchers from Belgium.

Highly active antiretroviral treatment can dramatically improve the quality of a HIV/AIDS patient’s life expectancy. This is especially helpful for patients with advanced HIV-1 disease. For this patients will have to have a full commitment to the antiviral treatment for life.

However researchers feel in prescribing HAART treatment for these people, physicians should be careful of the recent evidence of increasing cardiovascular and cerebrovascular accidents that are happening with the treatment.

Researchers feel that people infected with HIV have more risk of cardiovascular mortality on taking the HAART treatment than those who haven’t. HAART is associated with risk factors like increased plasma concentrations of triglycerides, total cholesterol, possibly hypertension, insulin resistance etc. HAART treatment can also induce endothelial dysfunction and thereby increase the risk of coronary disease.

Researchers suggest a total assessment of cardiovascular risk factors in patients who are affected with HIV/AIDS before prescribing the highly active antiretroviral treatment. This will make sure that the treatment is given to patients who are most likely to benefit from it.

The research was published in the British Medical Journal.

Reference: British Medical Journal, June 2005
'"/>




Page: 1

Related medicine news :

1. Britain Reconsidering New Visa Rules for Indian Doctors
2. Abbott Laboratories to buy Biocompatibles cardiovascular stent business
3. People who fight wars may be at high risk of cardiovascular disease
4. Low glycemic diet effective for reducing cardiovascular risk
5. Air pollution to affect diabetes patients’ cardiovascular risks
6. Lower risk of cardiovascular disease from tight glucose control
7. Leisure walks with low cardiovascular exercises work best for weight loss
8. Resilin Protein from Flea can be used for cardiovascular disease
9. Unfit teenagers and adults have a higher risk of cardiovascular diseases.
10. Statins reduces cardiovascular risk but no cancer risk.
11. Gene variants hold clues about vulnerability to cardiovascular disease
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/29/2017)... ... March 29, 2017 , ... The Professional ... it has enlisted New York City-based sports and entertainment marketing firm Leverage Agency ... sponsorship opportunities for the Professional Squash Association (PSA), which includes first-time ever title ...
(Date:3/29/2017)... ... March 30, 2017 , ... Sublime Naturals and its founder, Kathy ... "Wonder Spice", it has been used for thousands of years. , "The West has ... author of " Turmeric: How to Use it For Your Wellness. Overcome Inflammation, Enemy ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... provides insight into the challenges employers face in trying to balance both short-term ... employee benefits programs? Adding to the growing complexity, companies are finding that ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... documenting and diagramming network and data center assets and audio-video devices has recently ... request new equipment shapes for free and download shapes and stencils from ...
(Date:3/29/2017)... ... March 29, 2017 , ... Immunotherapy has emerged as one of ... and is touted to be the next revolution in our fight against this complex ... the form of immune checkpoint inhibitors such as PD-1 and PD-L1 inhibitors. , While ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... Calif. , March 29, 2017  Designers of ... significantly reduce solution size by 50% and extend battery ... ) power management integrated circuit (PMIC) from Maxim Integrated ... PMIC supports a low input voltage of just 0.7V ... Air and Silver Oxide, as well as the more ...
(Date:3/29/2017)... , March 29, 2017  NuVasive, Inc. (NASDAQ: ... transforming spine surgery with minimally disruptive, procedurally-integrated solutions, ... 510(k) clearance of the CoRoent® Small Interbody™ System ... levels in the cervical spine. This marks the ... be used at up to four contiguous levels. ...
(Date:3/29/2017)... HEIGHTS, Utah , March 29, 2017 /PRNewswire/ ... ) announced today the appointment of Cynthia ... Operations.  Cyndi will be responsible for leading Dynatronics ... organization and will report to Dynatronics, CEO ... Cyndi,s appointment concludes an extensive search process conducted ...
Breaking Medicine Technology: